Skip to main content
SpringerLink
Log in

Quality of life after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation: results from the SCALAF trial

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aims

In the SCALAF trial, catheter-based pulmonary vein isolation (PVI) was as effective in long-term prevention of atrial fibrillation (AF) as minimally invasive thoracoscopic PVI and left atrial appendage ligation (MIPI). Catheter ablation (CA) resulted in significantly less major complications as compare to MIPI. We report quality of life (QOL) outcome in these patients.

Methods

In this study, 52 patients with symptomatic paroxysmal or early persistent AF were randomized to either MIPI or CA. QOL was assessed at baseline, 3, 6, and 12 months follow-up using the SF-36 Health Survey Questionnaire. AF-related symptoms were quantified at each follow-up visit using the European Heart Rhythm Association (EHRA) score.

Results

Median age was 57 years and 78% was male. Paroxysmal AF was present in 74%. At 3 months follow-up, physical role limitations (88.2 ± 29.5; versus 40.9 ± 44.0; P = 0.001, respectively) and bodily pain scores (95.5 ± 8.7; versus 76.0 ± 27.8; P = 0.021, respectively) were significantly higher after CA compared to MIPI, indicating less limitation in daily activity caused by physical problems and less pain after CA than after MIPI. AF symptoms assessed by the EHRA scores improved significantly at 3, 6, 12, and 24 months compared to baseline in both treatment groups (P < 0.001), with no significant differences between treatment groups.

Conclusions

CA and MIPI ablation of AF both resulted in an improvement in several QOL measurements, although CA resulted in significantly less physical problems and bodily pain 3 months after treatment compared to MIPI.

Clinical trial number

ClinicalTrials.gov identifier: NCT00703157.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Calkins H, Hindricks G, Cappato R, Kim Y-H, Saad EB, Aguinaga L et al (2018) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 20(1):e1–e160

    Article  Google Scholar 

  2. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JGP, et al (2004) Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 43(2):241–247

    Article  Google Scholar 

  3. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ (2010) Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 3(6):615–623

    Article  Google Scholar 

  4. Wolf RK, Schneeberger EW, Osterday R, Miller D, Merrill W, Flege JBJ et al (2005) Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg 130(3):797–802

    Article  Google Scholar 

  5. Aliot E, Botto GL, Crijns HJ, Kirchhof P (2014) Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Europace 16(6):787–796

    Article  Google Scholar 

  6. Adiyaman A, Buist TJ, Beukema RJ, Smit JJJ, Delnoy PPHM, Hemels MEW et al (2018) Randomized controlled trial of surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation. Circ Arrhythm Electrophysiol 11(10):e006182

    Article  Google Scholar 

  7. Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD et al (2016) Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: meta-analysis of quality of life, morbidity, and mortality. JACC Clin Electrophysiol 2(2):170–180

    Article  Google Scholar 

  8. Kim YG, Shim J, Choi J-I, Kim Y-H (2016) Radiofrequency catheter ablation improves the quality of life measured with a short form-36 questionnaire in atrial fibrillation patients: a systematic review and meta-analysis. PLoS One 11(9):e0163755

    Article  Google Scholar 

  9. Fichtner S, Deisenhofer I, Kindsmuller S, Dzijan-Horn M, Tzeis S, Reents T et al (2012) Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. J Cardiovasc Electrophysiol 23(2):121–127

    Article  Google Scholar 

  10. Bagge L, Blomstrom P, Nilsson L, Einarsson GM, Jideus L, Blomstrom-Lundqvist C (2009) Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. J Thorac Cardiovasc Surg 137(5):1265–1271

    Article  Google Scholar 

  11. Driessen AHG, Berger WR, Bierhuizen MFA, Piersma FR, van den Berg NWE, Neefs J et al (2018) Quality of life improves after thoracoscopic surgical ablation of advanced atrial fibrillation: results of the Atrial Fibrillation Ablation and Autonomic Modulation via Thoracoscopic Surgery (AFACT) study. J Thorac Cardiovasc Surg 155(3):972–980

    Article  Google Scholar 

  12. Boersma LVA, Castella M, van Boven W, Berruezo A, Yilmaz A, Nadal M et al (2012) Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 125(1):23–30

    Article  Google Scholar 

  13. Pokushalov E, Romanov A, Elesin D, Bogachev-Prokophiev A, Losik D, Bairamova S et al (2013) Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol 24(12):1338–1343

    Article  Google Scholar 

  14. Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P et al (2013) Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial. Can J Cardiol 29(10):1211–1217

    Article  Google Scholar 

  15. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107(23):2920–2925

    Article  Google Scholar 

  16. Anderson SG, Shoaib A, Myint PK, Cleland JG, Hardman SM, McDonagh TA, Dargie H, Keavney B, Garratt CJ, Mamas MA (2019) Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01463-5 (Epub ahead of print, PMID: 30963233)

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P et al (2016) The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J 37(20):1591–1602

    Article  Google Scholar 

  18. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D et al (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial. Circulation 133(17):1637–1644

    Article  Google Scholar 

  19. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L et al (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378(5):417–427

    Article  Google Scholar 

  20. Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37(31):2478–2487

    Article  Google Scholar 

  21. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE et al (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA 321(13):1261–1274. https://doi.org/10.1001/jama.2019.0693

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH et al (2019) Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA 321(13):1275–1285. https://doi.org/10.1001/jama.2019.0692

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was sponsored by Medtronic.

Author information

Authors and Affiliations

  1. Department of Cardiology, Isala Heart Center, Dr. Van Heesweg 2, 8025 AB, Zwolle, The Netherlands

    Thomas J. Buist, Ahmet Adiyaman, Rypko J. Beukema, Jaap Jan J. Smit, Peter Paul H. M. Delnoy, Martin E. W. Hemels, Anand R. Ramdat Misier & Arif Elvan

  2. Department of Cardiothoracic Surgery, Isala Heart Center, Zwolle, The Netherlands

    Hauw T. Sie

Authors
  1. Thomas J. Buist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmet Adiyaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rypko J. Beukema
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jaap Jan J. Smit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Paul H. M. Delnoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Martin E. W. Hemels
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hauw T. Sie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anand R. Ramdat Misier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Arif Elvan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arif Elvan.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 80 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buist, T.J., Adiyaman, A., Beukema, R.J. et al. Quality of life after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation: results from the SCALAF trial. Clin Res Cardiol 109, 215–224 (2020). https://doi.org/10.1007/s00392-019-01504-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-019-01504-z

Keywords

Search

Navigation